Novel Marine Secondary Metabolites Worthy of Development as Anticancer Agents: A Review
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60076658%3A12310%2F21%3A43903966" target="_blank" >RIV/60076658:12310/21:43903966 - isvavai.cz</a>
Alternative codes found
RIV/60077344:_____/21:00551687
Result on the web
<a href="https://www.mdpi.com/1420-3049/26/19/5769" target="_blank" >https://www.mdpi.com/1420-3049/26/19/5769</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3390/molecules26195769" target="_blank" >10.3390/molecules26195769</a>
Alternative languages
Result language
angličtina
Original language name
Novel Marine Secondary Metabolites Worthy of Development as Anticancer Agents: A Review
Original language description
Secondary metabolites from marine sources have a wide range of biological activity. Marine natural products are promising candidates for lead pharmacological compounds to treat diseases that plague humans, including cancer. Cancer is a life-threatening disorder that has been difficult to overcome. It is a long-term illness that affects both young and old people. In recent years, significant attempts have been made to identify new anticancer drugs, as the existing drugs have been useless due to resistance of the malignant cells. Natural products derived from marine sources have been tested for their anticancer activity using a variety of cancer cell lines derived from humans and other sources, some of which have already been approved for clinical use, while some others are still being tested. These compounds can assault cancer cells via a variety of mechanisms, but certain cancer cells are resistant to them. As a result, the goal of this review was to look into the anticancer potential of marine natural products or their derivatives that were isolated from January 2019 to March 2020, in cancer cell lines, with a focus on the class and type of isolated compounds, source and location of isolation, cancer cell line type, and potency (IC50 values) of the isolated compounds that could be a guide for drug development.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Molecules
ISSN
1420-3049
e-ISSN
—
Volume of the periodical
26
Issue of the periodical within the volume
19
Country of publishing house
CH - SWITZERLAND
Number of pages
28
Pages from-to
—
UT code for WoS article
000709563200001
EID of the result in the Scopus database
—